Medical Facts

All Topics Released
  • What the Phase 1b/2 Trial Actually Showed — and What It Didn't
    The Cancer Interceptor: Inside the Lynch Syndrome Vaccine

    cancer vaccines
    lynch syndrome
    neoantigen
    oncology
    clinical trials

    A vaccine designed to intercept cancer in Lynch syndrome carriers produced a neoantigen-specific immune response in 100% of evaluable participants, with no serious adverse events. It has not yet been shown to prevent cancer.

    03 Feb 2026

Showing 1 to 1 of 1

← Prev Next →

Trends

Global Energy by Source: Fossil Fuels Still Supply 86%
Renewables Grew Fastest in 2025 — and Emissions Rose Anyway
Read More
Greenland's Rare Earths: World-Class and Years Away
A 15-14 Vote Didn't Change the Uranium Law — and First Ore Is Targeted for 2029
Read More
The Epstein Timeline: What Courts Actually Established
A Federal Judge Ruled Prosecutors Broke the Law by Hiding the 2008 Deal From Victims
Read More
Most Popular
View all
Related Topics
View all